115 related articles for article (PubMed ID: 304309)
1. Cellular immunity in squamous cell carcinoma of the uterine cervix.
Levy S; Kopersztych S; Musatti CC; Souen JS; Salvatore CA; Mendes NF
Am J Obstet Gynecol; 1978 Jan; 130(2):160-4. PubMed ID: 304309
[TBL] [Abstract][Full Text] [Related]
2. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
Bier J; Bitter K; Nicklisch U
J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210
[TBL] [Abstract][Full Text] [Related]
3. [Immune evaluation of cervical cancer patients--alteration of peripheral lymphocyte subpopulations--(author's transl)].
Ishiguro T
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):719-24. PubMed ID: 6972426
[TBL] [Abstract][Full Text] [Related]
4. T and B lymphocytes in patients with squamous cell carcinoma of the uterine cervix.
Ishiguro T; Sugitachi I; Katoh K
Gynecol Oncol; 1980 Feb; 9(1):80-5. PubMed ID: 6965486
[No Abstract] [Full Text] [Related]
5. Cell-mediated immunity in patients with carcinoma: correlation between clinical stage and immunocompetence.
Kopersztych S; Rezkallah MT; Miki SS; Naspitz CK; Mendes NF
Cancer; 1976 Sep; 38(3):1149-54. PubMed ID: 1085193
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro observation of cellular immune parameters in squamous cell carcinoma of the oral cavity and its correlation with tumor load and prognosis.
Das SN; Khanna NN; Khanna S
Cancer Invest; 1986; 4(3):207-16. PubMed ID: 3719410
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of leukocyte adherence by potassium chloride extract of allogeneic squamous cell carcinoma of the human uterine cervix.
Dini MM; Lenzi L; Faiferman I
Am J Reprod Immunol (1980); 1983 Jun; 3(4):188-90. PubMed ID: 6881415
[TBL] [Abstract][Full Text] [Related]
8. Determination of immunocompetent lymphocytes in patients with carcinoma of the lower jaw and the floor of the mouth.
Kühn R; Grigorov L; Yneva M
Folia Med (Plovdiv); 1985; 27(4):18-23. PubMed ID: 3938760
[No Abstract] [Full Text] [Related]
9. Delayed cutaneous hypersensitivity reactions to membrane extracts of carcinomatous cells of the cervix uteri.
Wells SA; Melewicz FC; Christiansen C; Ketcham AS
Surg Gynecol Obstet; 1973 May; 136(5):717-20. PubMed ID: 4701902
[No Abstract] [Full Text] [Related]
10. Cell-mediated immunity in patients with cervical cancer.
Cerni C; Tatra G; Berger R; Micksche M
Oncology; 1979; 36(4):164-70. PubMed ID: 224356
[TBL] [Abstract][Full Text] [Related]
11. T and B lymphocyte counts and blast transformation in patients with Stage I cervical cancer.
Kietlińska Z
Gynecol Oncol; 1984 Jun; 18(2):247-56. PubMed ID: 6610605
[TBL] [Abstract][Full Text] [Related]
12. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
13. T- and B-lymphocyte subpopulations following radiotherapy for invasive squamous cell carcinoma of the uterine cervix.
Rand RJ; Jenkins DM; Bulmer R
Clin Exp Immunol; 1978 Jul; 33(1):159-65. PubMed ID: 309370
[TBL] [Abstract][Full Text] [Related]
14. Cellular immunity as a host response to squamous carcinoma of the cervix.
Goldstein MS; Shore B; Gusberg SB
Am J Obstet Gynecol; 1971 Nov; 111(6):751-5. PubMed ID: 5166388
[No Abstract] [Full Text] [Related]
15. Cell-mediated cytotoxicity in preinvasive and invasive squamous cell carcinoma of the cervix.
Dini MM; Jafari K; Faiferman I
Obstet Gynecol; 1980 Jun; 55(6):728-31. PubMed ID: 7383460
[TBL] [Abstract][Full Text] [Related]
16. [Cellular immunity in carcinoma of the uterine cervix].
Pasqualini RS; Giraudo Conesa LC; Chevallier R
Medicina (B Aires); 1981; 41 Suppl():155-60. PubMed ID: 7345340
[No Abstract] [Full Text] [Related]
17. [Sensitization of lymphocyte to tumor extract detected by macrophage migration inhibition test(MIT) in patients with cervical cancer (author's transl)].
Ohno M
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jul; 32(7):919-28. PubMed ID: 7240870
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell activity in patients with invasive cervical carcinoma: importance of a longitudinal evaluation in follow-up.
Garzetti GG; Ciavattini A; Muzzioli M; Goteri G; Mannello B; Romanini C; Fabris N
Gynecol Obstet Invest; 1995; 40(2):133-8. PubMed ID: 8575692
[TBL] [Abstract][Full Text] [Related]
19. Leukocyte migration inhibition assay of tumor immunity in patients with cervical squamous cell carcinoma.
Rivera ES; Hersh EM; Bowen JM; Barnett JW; Wharton T; Murphy SG
Cancer; 1979 Jun; 43(6):2297-305. PubMed ID: 455220
[No Abstract] [Full Text] [Related]
20. [A correlation between the histological parameters such as stromal reaction and cell-mediated immune-structure of the regional lymph nodes, and the delayed cutaneous hypersensitive reaction toward DNCB in cervical cancer (author's transl)].
Obata N; Kodama S; Hando T; Hirogami T; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1980 May; 32(5):550-8. PubMed ID: 7240843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
